Rely on Worldwide for Successful Chronic Pain Clinical Trials
The United States Center for Disease Control and Prevention reports that more than 50 million Americans experience chronic pain, which is defined as pain experienced every day (or nearly every day) for at least six months. And more than 19 million Americans experience chronic pain of such magnitude that it has limited life or work activities for at least six months.
With more than 20% of the US population in chronic pain, the market for therapies aimed at alleviating pain is robust. So how can you bring your therapy to market as quickly as possible?
Trust Worldwide to help you make it happen. Since 2008, Worldwide has been involved in the design, execution, and analysis of more than 20 pain syndrome trials. Our experience covers areas from chronic lower back pain, osteoarthritis, mixed chronic pain, migraine, postherpetic neuralgia, diabetic peripheral neuropathy, distal symmetrical sensorimotor polyneuropathy, small fiber neuropathy, and more.
Worldwide has more than 30 years of experience supporting researchers bringing novel therapies to market. We’re internationally acclaimed experts in the area of clinical trial management. We offer full-service Phase I–Phase IV trial support, as well as real-world evidence clinical research services for ongoing studies about the efficacy of your chronic pain therapy.